Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

"Prices for dozens of generic drugs have uncharacteristically risen—some have skyrocketed—for no apparent reason," the federal lawsuit alleges. (Photo: Jamie/flickr/cc)

As Prices 'Skyrocket,' 20 States Sue Drug Companies for Collusion, Conspiracy

'We have evidence of widespread participation in illegal conspiracies across the generic drug industry,' says Connecticut attorney general

Deirdre Fulton

Twenty state attorneys general filed a lawsuit on Thursday against several pharmaceutical companies, accusing them of entering into "numerous illegal conspiracies" to fix generic drug prices at consumers' expense.

The federal lawsuit (pdf) names generic drug-makers Heritage Pharmaceuticals, Inc., Aurobindo Pharma USA, Inc., Citron Pharma, LLC, Mayne Pharma (USA), Inc., Mylan Pharmaceuticals, Inc., and Teva Pharmaceuticals USA, Inc., and concerns two drugs: doxycycline hyclate delayed release, an antibiotic used to treat a range of conditions including respiratory tract infections, and glyburide, an oral diabetes medication.

It was filed in the U.S. District Court for the District of Connecticut and labels Heritage as the "principal architect and ringleader" that helped organize a "wide-ranging series of conspiracies" to fix prices.

"The misconduct was conceived and carried out by senior drug company executives and their subordinate marketing and sales executives."
George Jepsen, Connecticut Attorney General

"My office has dedicated significant resources to this investigation for more than two years and has developed compelling evidence of collusion and anticompetitive conduct across many companies that manufacture and market generic drugs in the United States," said Connecticut Attorney General George Jepsen, who is leading the coalition.

The other plaintiff states are Delaware, Florida, Hawaii, Idaho, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Minnesota, Nevada, New York, North Dakota, Ohio, Pennsylvania, Virginia, and Washington.

"While the principal architect of the conspiracies addressed in this lawsuit was Heritage Pharmaceuticals, we have evidence of widespread participation in illegal conspiracies across the generic drug industry," Jepsen said. "Ultimately, it was consumers—and, indeed, our healthcare system as a whole—who paid for these actions through artificially high prices for generic drugs."

A release from Jepsen's office says "the misconduct was conceived and carried out by senior drug company executives and their subordinate marketing and sales executives," who "coordinated their schemes through direct interaction with their competitors at industry trade shows, customer conferences, and other events, as well as through direct email, phone, and text message communications."

For example, Reuters reports:

"While generic competition is supposed to bring prices down, these companies secretly agreed to rig the system to drive prices up at the expense of patients," Minnesota Attorney General Lori Swanson said in a statement.

She said a salesperson for Heritage in Minnesota played a key role in the scheme by organizing dinners among employees of competing drug companies when they visited the state.

"The dinners and meetings led to the exchange of information about the competitors' business plans and ultimately led to agreements on setting prices and/or allocating the market so as to avoid competing on price," a statement from Swanson's office said.

The news comes just one day after it was revealed that the U.S. Department of Justice has charged two former Heritage executives with conspiring to fix generic prices—"the first fruits of an ongoing and sweeping investigation into generic drug price-fixing by the Department," according to Ars Technica

As Bloomberg reported, guilty pleas and cooperation from the two executives "could lead to charges against executives at other drugmakers."

Forbes predicts "[t]he antitrust lawsuit and federal investigation will likely bring further political heat to the generic drug sector."

Indeed, the lawsuit charges: "Over the last several years, however, [the] price dynamic has changed for a large number of generic drugs. Prices for dozens of generic drugs have uncharacteristically risen—some have skyrocketed—for no apparent reason, sparking outrage from public officials, payers, and consumers across the country whose costs have doubled, tripled, or in some cases increased up to 1,000 percent or more."


Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

This is the world we live in. This is the world we cover.

Because of people like you, another world is possible. There are many battles to be won, but we will battle them together—all of us. Common Dreams is not your normal news site. We don't survive on clicks. We don't want advertising dollars. We want the world to be a better place. But we can't do it alone. It doesn't work that way. We need you. If you can help today—because every gift of every size matters—please do. Without Your Support We Simply Don't Exist.

Please select a donation method:

Donziger Slams Criminal Contempt Ruling as 'Message of Intimidation' to Human Rights Lawyers

"The United States has now become one of those countries where environmental advocates are attacked, put in jail, or even murdered for doing their jobs successfully."

Jake Johnson ·


Tributes Pour in for Civil Rights Activist Bob Moses, Dead at 86

"May his light continue to guide us as we face another wave of Jim Crow laws."

Brett Wilkins ·


Advocates Condemn Biden Plan to Send 4,000 Inmates Back to Prison After Pandemic

"As a candidate, Mr. Biden said he recognized the problems and injustices of mass incarceration, and he promised to reduce the federal prison population," wrote the Washington Post editorial board. "Here is a chance for him to keep that promise."

Julia Conley ·


As Climate Emergency Batters World, Scientists Meet to Finalize Key Report Ahead of COP26

"The decisions nations make in the next few months will likely determine whether we will or will not ultimately limit global temperature rise at 1.5°C," said the U.N.'s climate chief.

Kenny Stancil ·


'A Race Against Time': Doctors Without Borders Implores Rich Nations to Stop Stalling Patent Waiver

"As the virus continues to claim millions of lives around the world, we cannot afford to lose more precious time."

Jake Johnson ·